{
  "meta": {
    "title": "Secondary_Glaucomas",
    "url": "https://brainandscalpel.vercel.app/secondary-glaucomas-cb0c9165.html",
    "scrapedAt": "2025-11-29T18:31:18.149Z"
  },
  "questions": [
    {
      "id": 15224,
      "choices": [
        {
          "id": 60856,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#212121\">Primary Angle Closure Glaucoma</span></span></span></span></p>"
        },
        {
          "id": 60857,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#212121\">Neovascular Glaucoma</span></span></span></span></p>"
        },
        {
          "id": 60858,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#212121\">Posner Schlossman Syndrome</span></span></span></span></p>"
        },
        {
          "id": 60859,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#212121\">Iridocorneal Endothelial Syndrome</span></span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#212121\">A 34-year-old patient reported with complaints of blurring of vision in his left eye for the past 2 weeks. He had a past history of central retinal vein occlusion in the left eye, which was diagnosed almost 3 months back.&nbsp; Slit lamp examination revealed rubeosis iridis in all the four quadrants. The intraocular pressure (IOP) in left eye is 72&nbsp;mm of Hg. What is the diagnosis?</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#212121\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/02/02/picture35.jpg\" style=\"height:128px; width:300px\" /></span></span></span></span></p>",
      "unique_key": "Q8036700",
      "question_audio": null,
      "question_video": null,
      "map_id": 31247,
      "difficulty_level": "beginner",
      "subjects_id": [
        8
      ],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#212121\">Ans. B) Neovascular Glaucoma (NVG)</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#212121\">Option B:</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#212121\">NVG has been called <strong>&#39;90&#39;</strong> or <strong>&#39;100-day glaucoma&#39;</strong> in the past due to its typical development <strong>3 months</strong> after the <strong>onset</strong> of <strong>CRVO</strong>.</span></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#212121\">Pathogenesis:</span></span></u></span></span>\r\n\t<ul style=\"list-style-type:circle\">\r\n\t\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#212121\">Hypoxic retinal tissue&nbsp;</span></span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#212121\">produces <strong>angiogenic factors</strong> (like <strong>VEGF</strong>) in an <strong>attempt</strong> to <strong>Revascularize Hypoxic Areas</strong>. </span></span></span></span></li>\r\n\t\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#212121\">The new vessels encroach on the <strong>angle</strong> and <strong>cause open angle glaucoma</strong>. Later when a <strong>neovascular membrane</strong> is formed, <strong>contraction</strong> of the membrane causes <strong>angle closure glaucoma</strong>. </span></span></span></span></li>\r\n\t</ul>\r\n\t</li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#212121\">Causes:</span></span></u></span></span>\r\n\t<ul style=\"list-style-type:circle\">\r\n\t\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#212121\">Diabetic Retinopathy&nbsp;</span></span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#212121\">(most common)</span></span></span></span></li>\r\n\t\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#212121\">Central Retinal Vein Occlusion&nbsp;</span></span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#212121\">(<strong>CRVO</strong>) </span></span></span></span></li>\r\n\t</ul>\r\n\t</li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A. Primary Angle Closure Glaucoma&nbsp;</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">is caused by the <strong>physical closure</strong> of the <strong>anterior chamber angle</strong>, leading to <strong>increased IOP</strong>. It does not typically involve rubeosis iridis.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. Posner-Schlossman Syndrome,&nbsp;</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">also known as <strong>Glaucomatocyclitic Crisis</strong>, this condition typically presents with <strong>mild elevation</strong> of <strong>IOP</strong> and not with rubeosis iridis. It&#39;s characterized by <strong>recurrent attacks</strong> of <strong>mild inflammation</strong> and <strong>elevated IOP</strong>.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. Iridocorneal Endothelial Syndrome&nbsp;</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">rare condition <strong>affects</strong> the <strong>cornea</strong> and <strong>iris</strong> and can lead to <strong>secondary glaucoma</strong>. It does not typically involve rubeosis iridis.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective: </span></u></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Considering the <strong>presence&nbsp;</strong>of <strong>rubeosis iridis</strong> in <strong>all four quadrants</strong> and the <strong>significantly</strong> <strong>elevated IOP</strong>, the <strong>diagnosis</strong> is <strong>Neovascular Glaucoma</strong>. This condition is often a <strong>consequence</strong> of <strong>ischemic retinal diseases</strong> and presents with <strong>new blood vessel formation</strong> on the <strong>iris</strong> and <strong>angle</strong>, leading to <strong>increased intraocular pressure</strong> due to <strong>impaired</strong> <strong>aqueous humor drainage</strong>.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref:&nbsp;</span></u></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Kanski&rsquo;s Clinical Ophthalmology, 8th Edition, Page 371, 372</span></strong></span></span></p>",
      "correct_choice_id": 60857,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased",
        "ImageBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 15208,
      "choices": [
        {
          "id": 60792,
          "text": "<p><span style=\"color:black;font-size:12pt;\">Pseudo-Exfoliation</span><span style=\"font-size:12pt;\"> Glaucoma</span></p>"
        },
        {
          "id": 60793,
          "text": "<p><span style=\"color:black;font-size:12pt;\">Uveitis Glaucoma</span></p>"
        },
        {
          "id": 60794,
          "text": "<p><span style=\"color:black;font-size:12pt;\">Pigmentary Glaucoma</span></p>"
        },
        {
          "id": 60795,
          "text": "<p><span style=\"color:black;font-size:12pt;\">Traumatic Glaucoma</span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify;\"><span style=\"color:black;font-size:12pt;\">A&nbsp;</span><span style=\"color:#333333;font-size:12pt;\">65-year-old male presented to the OPD with complaints of painless, gradually progressive reduction of vision of the right eye over several months. IOP was OD: 55mmHg and OS: 19mmHg. Anterior chamber was of normal depth in both eyes. A white flaky disc was seen on the anterior lens capsule after dilatation in both eyes. What is the probable diagnosis?</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"color:#333333;font-size:12pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/02/02/picture20.jpg\" alt=\"\" width=\"300\" height=\"260\"></span></p>",
      "unique_key": "Q1835687",
      "question_audio": null,
      "question_video": null,
      "map_id": 31241,
      "difficulty_level": "beginner",
      "subjects_id": [
        8
      ],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. A) </strong></span><span style=\"color:black;font-size:12pt;\"><strong>Pseudo-Exfoliation</strong></span><span style=\"font-size:12pt;\"> <strong>Glaucoma</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option A:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"color:black;font-size:12pt;\"><strong>Exfoliation Syndrome&nbsp;</strong>(XFS)/ <strong>Pseudo-Exfoliation Syndrome</strong> are an age-related disease <strong>characterized</strong> by the <strong>production</strong> and <strong>progressive accumulation</strong> of <strong>Fibrillar Extracellular Material</strong> in <strong>Ocular Tissues</strong>.</span></li><li><span style=\"color:black;font-size:12pt;\"><strong>Glaucoma&nbsp;</strong>in <strong>Pseudo-Exfoliation</strong> can exhibit as <strong>Open-Angle</strong> or <strong>Angle-Closure Glaucoma</strong>.</span></li></ul><p>&nbsp;</p><p><span style=\"color:black;font-size:12pt;\"><strong><u>Characteristic features are:</u></strong></span></p><p>&nbsp;</p><ul><li><span style=\"color:black;font-size:12pt;\"><strong>Lens</strong>: The most commonly recognized feature is the <strong>3-ring sign</strong> on the <strong>anterior lens capsule</strong> formed by a <strong>central disc</strong>, a <strong>peripheral ring</strong>, and a <strong>clear zone</strong>, in between.</span></li><li><span style=\"color:black;font-size:12pt;\"><strong>Iris</strong>: <strong>Fine flaky</strong> <strong>white material</strong> can be seen on the <strong>pupillary border</strong> of the <strong>iris</strong> <strong>without dilation</strong></span></li><li><span style=\"color:black;font-size:12pt;\"><strong>Pupil:&nbsp;Eyes&nbsp;</strong>with <strong>XFS</strong> often <strong>dilate poorly</strong>.</span></li><li><span style=\"color:black;font-size:12pt;\"><strong>Zonules and Ciliary Body:&nbsp;Exfoliation material (XFM)&nbsp;</strong>may be detected earliest on the <strong>ciliary processes</strong> and <strong>zonules</strong> and this creates a <strong>tendency</strong> for <strong>spontaneous subluxation</strong> or <strong>dislocation</strong> of the <strong>crystalline lens</strong> in <strong>advanced cases</strong>.</span></li></ul><p>&nbsp;</p><p><span style=\"color:black;font-size:12pt;\"><strong><u>Explanation:</u></strong></span></p><p>&nbsp;</p><p><span style=\"color:black;font-size:12pt;\"><strong>Option B. Uveitis Glaucoma&nbsp;</strong>is <strong>secondary</strong> to <strong>uveitis</strong>. Signs of <strong>active inflammation</strong>, such as <strong>cells</strong> and <strong>flare</strong> in the <strong>anterior chamber</strong> or <strong>synechiae</strong> (<strong>adhesion</strong> of the <strong>iris</strong> to the <strong>lens</strong> or <strong>cornea</strong>), might be <strong>expected</strong>.</span></p><p>&nbsp;</p><p><span style=\"color:black;font-size:12pt;\"><strong>Option C. Pigmentary glaucoma&nbsp;</strong>is caused by the <strong>dispersion</strong> of <strong>pigment granules</strong> from the <strong>iris</strong> into <strong>aqueous humor</strong>. This pigment can clog the <strong>trabecular meshwork</strong>, <strong>increasing intraocular pressure</strong>. Typical signs include <strong>mid-peripheral iris transillumination defects</strong>, <strong>dense pigmentation</strong> of the <strong>trabecular meshwork</strong>, and a <strong>Krukenberg spindle</strong> (a <strong>vertical deposition</strong> of <strong>pigment</strong> on the <strong>corneal endothelium</strong>).</span></p><p>&nbsp;</p><p><span style=\"color:black;font-size:12pt;\"><strong>Option D. Traumatic glaucoma&nbsp;</strong>can occur following an <strong>injury</strong> to the <strong>eye</strong> and can present with various signs <strong>depending</strong> on the <strong>mechanism of injury</strong>. Features might include <strong>irregularities</strong> of the <strong>pupil</strong>, <strong>signs of angle recession</strong>.</span></p><p>&nbsp;</p><p><span style=\"color:black;font-size:12pt;\"><strong><u>Educational Objective:</u></strong></span></p><p>&nbsp;</p><p><span style=\"color:black;font-size:12pt;\">Characterized by <strong>Flaky, Dandruff-like material</strong> depositing on the <strong>lens</strong>, <strong>Pupillary Border</strong>, and other structures within the eye. This material can be visualized during an <strong>Eye Examination</strong> and can <strong>lead</strong> to <strong>Increased Intraocular Pressure</strong>.</span></p><p>&nbsp;</p><p><span style=\"color:black;font-size:12.0pt;\"><strong><u>Ref:&nbsp;</u>Comprehensive&nbsp;</strong></span><span style=\"font-size:12.0pt;\"><strong>Ophthalmology, A K Khurana, 5<sup>th</sup> Edition, Page 250</strong></span></p>",
      "correct_choice_id": 60792,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased",
        "ImageBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 15191,
      "choices": [
        {
          "id": 60724,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Sturge Weber Syndrome</span></span></span></span></p>"
        },
        {
          "id": 60725,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Neovascular Glaucoma</span></span></span></span></p>"
        },
        {
          "id": 60726,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Neurofibromatosis</span></span></span></span></p>"
        },
        {
          "id": 60727,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Peters Anomaly</span></span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Raised Episcleral Pressure is seen in?</span></span></span></span></p>",
      "unique_key": "Q3768172",
      "question_audio": null,
      "question_video": null,
      "map_id": 31246,
      "difficulty_level": "difficult",
      "subjects_id": [
        8
      ],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. A) Sturge Weber Syndrome</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Sturge-Weber syndrome</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> (Encephalotrigeminal Angiomatosis)</span></span></span>\r\n\r\n\t<ul style=\"list-style-type:circle\">\r\n\t\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Congenital</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">, <strong>Sporadic Phacomatosis</strong>.</span></span></span></li>\r\n\t\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">30%&nbsp;</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">patients develop <strong>Glaucoma Ipsilateral</strong> to the <strong>Facial Hemangioma</strong>. </span></span></span></li>\r\n\t\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Pathogenesis of Glaucoma: </span></u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">uncertain. May be due to <strong>trabeculodysgenesis in infants</strong> and <strong>in older patients, </strong>may be due to<strong> raised episcleral venous pressure</strong> associated with <strong>arteriovenous communication</strong> in an <strong>episcleral hemangioma</strong>.</span></span></span></li>\r\n\t\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#374151\">Raised episcleral pressure&nbsp;</span></span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#374151\">is most often associated with conditions that <strong>obstruct</strong> the <strong>venous outflow</strong> from the eye, such as <strong>carotid cavernous fistula</strong> or <strong>orbital tumors</strong>.</span></span></span></span></li>\r\n\t</ul>\r\n\t</li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#374151\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/02/02/screenshot-2024-02-02-122128.jpg\" style=\"height:283px; width:1000px\" /></span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">. <strong>Neovascular Glaucoma:&nbsp;</strong>(Pre-Trabecular) Seen in <strong>retinal ischemia</strong> causing <strong>neovascularization</strong> over <strong>iris</strong> (<strong>rubeosis iridis</strong>) and <strong>consequent fibrosis</strong>, leading to <strong>zip-like adhesions</strong> of <strong>iris</strong> to the <strong>cornea</strong> at the <strong>angle</strong>.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. Neuro-Fibromatosis:&nbsp;</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Glaucoma is <strong>rare</strong>. If develops, is <strong>usually unilateral</strong> and <strong>congenital</strong>. Various mechanisms have been <strong>identified</strong>, including congenital <strong>Angle Anomaly</strong>.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. Peters Anomaly:&nbsp;</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Glaucoma occurs in <strong>about 50%</strong> due to associated <strong>Angle Anomaly</strong>.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#374151\">Educational Objective:</span></span></u></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#374151\">Sturge-Weber Syndrome&nbsp;</span></span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#374151\">is associated with <strong>raised episcleral pressure</strong> related to <strong>vascular malformations</strong>. It is a cause of <strong>congenital glaucoma</strong>.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><strong><u><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref:</span></span></u> </strong><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Kanski&rsquo;s Clinical Ophthalmology, 8<sup>th</sup> Edition, Page 394</span></span></strong></p>",
      "correct_choice_id": 60724,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 15248,
      "choices": [
        {
          "id": 60952,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#212121\">Primary Open Angle Glaucoma</span></span></span></span></p>"
        },
        {
          "id": 60953,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#212121\">Pseudoexfoliation Glaucoma</span></span></span></span></p>"
        },
        {
          "id": 60954,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#212121\">Phacomorphic Glaucoma</span></span></span></span></p>"
        },
        {
          "id": 60955,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#212121\">Uveitic Glaucoma</span></span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">A patient arrives at the emergency department complaining of a sudden and painful loss of vision in one eye. Upon carrying out slit lamp examination, findings include 4 + anterior chamber cells, 2+ flare, a fibrinous membrane covering the pupillary area and elevated intraocular pressure. What is the likely diagnosis based on these observations?</span></span></span></span></p>",
      "unique_key": "Q8239054",
      "question_audio": null,
      "question_video": null,
      "map_id": 31244,
      "difficulty_level": "intermediate",
      "subjects_id": [
        8
      ],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#212121\">Ans. D) Uveitic Glaucoma</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#212121\">Option D:&nbsp;</span></span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#212121\">The given clinical scenario is of a patient who has <strong>developed glaucoma secondary</strong> to an <strong>inflammatory condition</strong>.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"color:#212121\"><strong>UVEITIC GLAUCOMA: Increased IOP</strong>&nbsp;</span></span><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#212121\"><strong>secondary</strong> to <strong>inflammation</strong> of <strong>uveal tissue</strong> (<strong>iridocyclitis</strong>)</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#212121\">Signs of Anterior uveitis:</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#212529\">Aqueouscells</span></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#212529\">Keratic Precipitates</span></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#212529\">AqueousFlare (protein leaked from damaged blood vessels)</span></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#212529\">Hypopyon</span></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#212529\">Iris nodules</span></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#212529\">Posterior synechiae</span></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#212529\">Pupil miosis</span></span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#212121\">Secondary glaucoma as a complication of Anterior uveitis:</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ol>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#212121\">Early glaucoma:</span></span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#212121\"> In the <strong>active phase</strong>, the <strong>inflammatory exudates&nbsp;</strong>and <strong>cells clog</strong> the <strong>outflow tract</strong> of <strong>aqueous humour leading</strong> to <strong>raised IOP</strong>.</span></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#212121\">Late glaucoma:</span></span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#212121\"> The <strong>pupil block</strong> due to <strong>seclusio pupillae</strong> (<strong>ring synechiae</strong>) or <strong>occlusion pupillae</strong> (<strong>organized exudates</strong>) <strong>doesn&rsquo;t allow aqueous</strong> to <strong>flow</strong> from <strong>posterior</strong> to the <strong>anterior chamber</strong>. <strong>Peripheral anterior synechiae</strong> may be formed.</span></span></span></span></li>\r\n</ol>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#212121\">Explanation:</span></span></u></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#212121\">Option A. Primary Open Angle Glaucoma</span></span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#212121\">: Typically presents with a <strong>gradual loss</strong> of <strong>peripheral vision</strong> over time, not sudden and painful loss of vision. There is also no association with anterior chamber inflammation (cells and flare).</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#212121\">Option B. Pseudo exfoliation Glaucoma&nbsp;</span></span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#212121\">is associated with the <strong>deposition</strong> of <strong>fibrillar material</strong> in the <strong>anterior segment</strong> and other parts of the eye. It usually does not present with acute symptoms and inflammation like anterior chamber cells and flare.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#212121\">Option C. Phacomorphic Glaucoma&nbsp;</span></span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#212121\">c</span></span><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#212121\">aused by a <strong>swollen cataractous lens</strong> leading to <strong>angle closure</strong> and <strong>elevated IOP</strong>. While it can <strong>present</strong> with a <strong>sudden</strong> <strong>loss of vision</strong> and <strong>elevated IOP</strong>, it does not typically present with anterior uveitis (cells and flare in the anterior chamber).</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#212121\">Educational Objective: </span></span></u></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#212121\">The diagnosis with the <strong>combination&nbsp;</strong>of <strong>sudden</strong> and <strong>painful vision loss</strong>, <strong>anterior chamber inflammation</strong>, <strong>fibrin membrane coveing</strong> the <strong>pupillary area</strong> and <strong>elevated IOP</strong> is <strong>Uveitic Glaucoma</strong>. </span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#212121\">Ref:&nbsp;</span></span></u></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#212121\">Comprehensive&nbsp;</span></span></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Ophthalmology, A K Khurana, 5<sup>th</sup> Edition, Page 249</span></span></strong></span></span></p>",
      "correct_choice_id": 60955,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 15253,
      "choices": [
        {
          "id": 60972,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#333333\">Uveitic Glaucoma</span></span></span></span></p>"
        },
        {
          "id": 60973,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#333333\">Phacomorphic Glaucoma</span></span></span></span></p>"
        },
        {
          "id": 60974,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#333333\">Pigmentary Glaucoma</span></span></span></span></p>"
        },
        {
          "id": 60975,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#333333\">Malignant Glaucoma</span></span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#333333\">A 52-year-old male came with complaints of severe pain and defective vision in the right eye for the past 2 days. Examination showed Circumcorneal Congestion, Anterior Chamber was shallow, lens showed intumescent Cataract. Intraocular Pressure is 42 mm of Hg. The probable diagnosis is?</span></span></span></p>",
      "unique_key": "Q9710978",
      "question_audio": null,
      "question_video": null,
      "map_id": 31245,
      "difficulty_level": "beginner",
      "subjects_id": [
        8
      ],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. B) Phacomorphic Glaucoma </span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Phacomorphic glaucoma is the <strong>increase</strong> in <strong>intraocular pressure</strong> due to <strong>swollen cataractous lens</strong> (intumescent cataract)</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Swollen lens pushes the <strong>iris forward</strong> &amp; <strong>obliterates</strong> the <strong>angle</strong> resulting in <strong>secondary acute angle closure glaucoma</strong>.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Treatment- <strong>Control</strong> the <strong>IOP</strong> &amp; <strong>removal</strong> of <strong>cataractous lens</strong>.</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/02/02/picture40.jpg\" style=\"height:213px; width:350px\" /></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A. Uveitic Glaucoma:&nbsp;</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">In an <strong>acute attack</strong>, signs of <strong>anterior uveitis</strong> would be <strong>present</strong>, presents as <strong>SOAG</strong>. If <strong>chronic</strong>, <strong>seclusion pupillae</strong>, <strong>iris bombe</strong>, <strong>peripheral anterior synechiae</strong>, <strong>scarring</strong> of the <strong>trabeculum</strong> may be <strong>present</strong>.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">. <strong>Pigmentary Glaucoma</strong>: Secondary to Pigment Dispersion syndrome. </span><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Secondary pigment dispersion&nbsp;</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">can occur as a <strong>consequence</strong> of <strong>trauma</strong>, <strong>intraocular tumour</strong> and <strong>rubbing</strong> of a <strong>malpositioned IOL</strong> on the <strong>iris pigment epithelium</strong>. Pigment granules from iris pigment epithelium and their deposition throughout the <strong>anterior segment</strong> is seen.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">. <strong>Malignant Glaucoma:&nbsp;</strong>also known as <strong>Ciliary block glaucoma</strong>, is a <strong>rare serious complication</strong> of <strong>trabeculectomy</strong>.&nbsp;</span><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">It is caused by <strong>anterior rotation</strong> of the <strong>ciliary processes</strong> and <strong>iris root</strong> (<strong>ciliolenticular block</strong>) leading to a <strong>posterior misdirection</strong> of <strong>aqueous</strong>.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Identify that the <strong>clinical presentation</strong> of <strong>severe ocular pain</strong>, <strong>high intraocular pressure</strong>, <strong>circumcorneal congestion</strong>, a <strong>shallow anterior chamber</strong>, and an <strong>intumescent cataract</strong> is indicative of <strong>Phacomorphic Glaucoma</strong>, a type of <strong>secondary angle-closure glaucoma</strong> caused by <strong>lens</strong>-<strong>induced blockage</strong> of the <strong>anterior chamber angle</strong>.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><strong><u><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref:&nbsp;</span></span></u></strong><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Comprehensive Ophthalmology, A K Khurana, 5<sup>th</sup> Edition, Page 248</span></span></strong></p>",
      "correct_choice_id": 60973,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 15269,
      "choices": [
        {
          "id": 61036,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Timolol</span></span></span></p>"
        },
        {
          "id": 61037,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Latanoprost </span></span></span></p>"
        },
        {
          "id": 61038,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Dorzolamide </span></span></span></p>"
        },
        {
          "id": 61039,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Brimonidine </span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A patient who is a known case of chronic uveitis presented with raised intraocular pressure. Which of the following drugs is not preferred in this patient?</span></span></span></p>",
      "unique_key": "Q9649461",
      "question_audio": null,
      "question_video": null,
      "map_id": 31240,
      "difficulty_level": "intermediate",
      "subjects_id": [
        8
      ],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. B) Latanoprost </span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Prostaglandin analogues&nbsp;</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">act by <strong>increasing</strong> the <strong>uveoscleral outflow</strong>.</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">These drugs are used as <strong>first-line agents</strong> in treatment of <strong>glaucoma</strong>.</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Anterior uveitis&nbsp;</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">is one of a <strong>rare complication</strong>, hence it should be used with <strong>caution</strong> in <strong>inflamed eyes</strong>.</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Other <strong>ocular side-effects</strong>:</span></span></span>\r\n\t<ul>\r\n\t\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Conjunctival hyperaemia</span></span></span></li>\r\n\t\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Eyelash lengthening, thickening, hyperpigmentation</span></span></span></li>\r\n\t\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Irreversible iris pigmentation</span></span></span></li>\r\n\t\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Reversible hyperpigmentation of periocular skin</span></span></span></li>\r\n\t\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Periocular atrophy</span></span></span></li>\r\n\t\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Increased chances of cystoid macular edema post cataract surgery.</span></span></span></li>\r\n\t</ul>\r\n\t</li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A. Timolol&nbsp;</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">is a <strong>beta-blocker</strong> used to <strong>lower IOP</strong>. It does not typically exacerbate uveitis and can be used unless there are other contraindications (like <strong>asthma</strong> or <strong>heart block</strong>). However, <strong>systemic absorption</strong> of <strong>beta-blockers</strong> can have <strong>cardiovascular</strong> and <strong>respiratory effects</strong>.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. Dorzolamide&nbsp;</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">is a <strong>topical carbonic anhydrase inhibitor</strong>. It <strong>decreases aqueous humor production</strong> and is generally <strong>safe</strong> in uveitis without specific contraindications.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">. <strong>Brimonidine</strong> is an <strong>alpha-2 adrenergic agonist</strong>. While it <strong>effectively lowers IOP</strong> by <strong>decreasing aqueous humor production</strong> and <strong>increasing uveoscleral outflow</strong>, <strong>brimonidine</strong> can have a <strong>higher risk</strong> of <strong>allergic reactions</strong>.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective: </span></u></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Latanoprost&nbsp;</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">and other <strong>prostaglandin analogues</strong>, can <strong>potentially increase intraocular</strong> <strong>inflammation</strong> or <strong>exacerbate pre-existing uveitis</strong>.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref:&nbsp;</span></u></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">KANSKI 9<sup>TH</sup> EDITION PAGE 405</span></strong></span></span></p>",
      "correct_choice_id": 61037,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 15278,
      "choices": [
        {
          "id": 61072,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">1% Medrysone</span></span></span></p>"
        },
        {
          "id": 61073,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">0.5% Loteprednol Etabonate </span></span></span></p>"
        },
        {
          "id": 61074,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">0.1% Fluorometholone</span></span></span></p>"
        },
        {
          "id": 61075,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">0.1% Dexamethasone </span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Which of the following topical steroid drugs has the high potency for elevating IOP? </span></span></p>",
      "unique_key": "Q4785079",
      "question_audio": null,
      "question_video": null,
      "map_id": 31242,
      "difficulty_level": "intermediate",
      "subjects_id": [
        8
      ],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. D) 0.1% Dexamethasone</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The <strong>rates&nbsp;</strong>of <strong>IOP spikes</strong> for various <strong>steroids differ</strong> and <strong>depend</strong> on the <strong>potency</strong>, <strong>formulation</strong>, and <strong>delivery</strong> of the <strong>particular drug</strong>.</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The <strong>rise</strong> in <strong>IOP</strong> may be <strong>attribute</strong> to <strong>deposition</strong> of <strong>glycosaminoglycans</strong> in the <strong>TM</strong>.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A. 1% Medrysone&nbsp;</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">is <strong>a relatively weak steroid</strong> and has a <strong>lower potential</strong> for <strong>raising IOP</strong> compared to <strong>more potent steroids</strong>.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B. 0.5% Loteprednol Etabonate&nbsp;</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">is designed to have a <strong>lower IOP-elevating potential</strong>. It is an <strong>ester steroid</strong>, which is <strong>metabolized</strong> into <strong>inactive metabolites</strong>, <strong>reducing</strong> the <strong>risk</strong> of <strong>increased IOP</strong>.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. 0.1% Fluorometholone&nbsp;</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">is also considered to have a <strong>lower potential</strong> for <strong>increasing IOP</strong> compared to <strong>more potent steroids</strong>. It is often chosen for patients who are more <strong>susceptible</strong> to <strong>steroid induced IOP elevation</strong>.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The <strong>IOP rising potency</strong> of various <strong>topical steroids</strong> are as follows:</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Difluprednate &gt; Dexamethasone &gt; Prednisolone &gt; Fluorometholone &gt; Medrysone</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><strong><u><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref</span></span></u><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">:&nbsp;</span></span></strong><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">AAO SECTION: 2 &ndash; 2020 EDITION PAGE 402</span></span></strong></p>",
      "correct_choice_id": 61075,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 18511,
      "choices": [
        {
          "id": 74002,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Miosis </span></span></span></span></p>"
        },
        {
          "id": 74003,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Iris Pigmentation </span></span></span></span></p>"
        },
        {
          "id": 74004,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Brow Ache </span></span></span></span></p>"
        },
        {
          "id": 74005,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Accommodative Spasm </span></span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">In a patient using Pilocarpine eye drops, which side effect is not expected?</span></span></span></p>",
      "unique_key": "Q9204010",
      "question_audio": null,
      "question_video": null,
      "map_id": 31243,
      "difficulty_level": "intermediate",
      "subjects_id": [
        8
      ],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. B) Iris Pigmentation</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">In eyes having a <strong>narrow angle recess</strong> or <strong>angle-closure glaucoma</strong>, <strong>constriction</strong> of the <strong>pupil pulls</strong> the <strong>peripheral iris</strong> away from the <strong>angle structures</strong>, opening a <strong>functionally closed angle</strong>.</span></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">It is <strong>commonly</strong> used as <strong>2&ndash;4% drops 6&ndash;8 hourly</strong>. </span></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Side effects: <strong>Miosis</strong>, <strong>Brow Ache</strong> and accommodative <strong>Spasm</strong>. </span></span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A.&nbsp;</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Miosis, or constriction of the pupil, is a <strong>direct effect</strong> of <strong>pilocarpine</strong>. By <strong>stimulating muscarinic receptors</strong> in the <strong>iris sphincter muscle</strong>, pilocarpine causes the <strong>pupils</strong> to <strong>constrict</strong>. This is an <strong>expected side effect</strong>.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">. Brow ache or headache is a <strong>common side effect</strong> of <strong>pilocarpine</strong>. This occurs due to the <strong>contraction</strong> of the <strong>ciliary muscle</strong> and the <strong>muscles</strong> of the <strong>iris</strong>, which can cause <strong>discomfort</strong> around the <strong>eyes</strong> and <strong>forehead</strong>.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">. Pilocarpine can cause <strong>accommodative spasm</strong>, which is an <strong>involuntary contraction</strong> of the <strong>ciliary muscle</strong> leading to <strong>excessive focusing ability</strong> of the <strong>eye</strong> for <strong>near vision</strong>. This can result in <strong>blurred vision</strong> for <strong>distance</strong> and <strong>eye strain</strong>.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective</span></u></strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: </span></u></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">While pilocarpine, a <strong>cholinergic agonist</strong>, commonly causes <strong>miosis</strong>, <strong>brow ache</strong>, and accommodative <strong>spasm</strong> as <strong>side effects</strong> due to its <strong>mechanism</strong> of <strong>action</strong>, it does not cause increased iris pigmentation, which is more typical of <strong>prostaglandin analogues</strong>.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><strong><u><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref:&nbsp;</span></span></u><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">PARSONS DISEASES OF EYE 22<sup>ND</sup> EDITION PAGE 156</span></span></strong></p>",
      "correct_choice_id": 74003,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    }
  ]
}